pH dependence of a 3-helix versus a turn in the M-loop region of PDE4: Observations on PDB entries and an electronic structure study

Journal of Chemical Theory and Computation

Volumn 4, Issue 6, 2008, Pages 974-984

  Usharani, Dandamudi ^a,b   Srivani, Lakuri ^c   Sastry, G Narahari ^c   Jemmis, Eluvathingal D ^b  

^a UNIVERSITY OF HYDERABAD   (India)

^b INDIAN INSTITUTE OF SCIENCE   (India)

^c INDIAN INSTITUTE OF CHEMICAL TECHNOLOGY   (India)

Author keywords

[No Author keywords available]

Indexed keywords

EID: 58149114921     PISSN: 15499618     EISSN: None     Source Type: Journal    
DOI: 10.1021/ct700261b     Document Type: Article

References (57)

1. (a) Bender, A. T.; Baevo, A. J. Cyclic Nucleotide Phosphodiesterases: Molecular Regulation to Clinical Use. Pharmacol Rev. 2006, 58, 488-520.
2. (b) Houslay, M. D. PDE4-cAMP-specific Phosphodiesterases. Prog. Nucleic Acid Res. Mol. Biol. 2001, 69, 249-315.
3. (c) Chung, K. F. Phosphodiesterase Inhibitors in Airways Disease. Eur. J. Pharmacol. 2006, 533, 110-117.
4. (d) Boswell-Smith, B.; Spina, D.; Page, C. P. Phosphodiesterase inhibitors. Br. J. Pharmacol. 2006, 147, S252-S257.
5. (a) Castro, A.; Jerez, M. J.; Martinez, A.; Gil, C. Cyclic nucleotide Phosphodiesterases and their Role in Immunomodulatory Responses: Advances in the Development of Specific Phosphodiesterase Inhibitors. Med. Res. Rev. 2005, 25, 229-244.
6. (b) Zhang, K. Y. J.; Ibrahim, P. N.; Gillette, S.; Bollag, G. Phosphodiesterase 4 as a Potential Drug Target. Exp. Opin. Ther. Drugs 2005, 9, 1283-1304.
7. (c) Houslay, M. D.; Schafer, P.; Zhang, K. Y. J. Phosphodiesterase-4 as Therauptic target. Drug Discovery Today 2005, 10, 1503-1519.
8. (a) Jeon, J. H.; Heo, Y.-S.; Kim, C. M.; Hyun, Y.-L.; Lee, T. G.; Ro, S.; Cho, J. M. Phosphodiestrase: Overview of Protein Structures, Potential Therapeutic Applications and Recent progress in Drug Development. Cell. Mol. Life Sci. 2005, 62, 1198-1220.
9. (b) Srivani, P.; Srinivas, E.; Raghu, R.; Sastry, G. N. Molecular Docking Studies of Pyridopurinone Derivatives - Potential Phosphodiesterases Inhibitor. J. Mol. Graphics Modell. 2007, 26, 378-390.
10. Xu, R. X.; Hassell, A. M.; Vanderwall, D.; Lambert, M. H.; Holmes, W. D.; Luthe, M. A.; Rocque, W. J.; Milburn, M. V.; Zhao, Y.; Ke, H.; Nolte, R. T. Atomic structure of PDE4: Insight into Phosphodiesterase Mechanism and Specificity. Science 2000, 288, 1822-1825.
11. Lee, M. E.; Markowitz, J.; Lee, J.-O.; Lee, H. Crystal structure of Phosphodiesterase 4D and Inhibitor complex. FEBS Lett. 2002, 530, 53-58.
12. (a) Huai, Q.; Wang, H.; Sun, Y.; Kim, H.-Y.; Liu, Y.; Ke, H. Three-dimensional Structures of PDE4D in Complex with Roliprams and Implication on Inhibitor selectivity. Structure 2003, 11, 865-873.
13. (b) Huai, Q.; Liu, Y.; Francis, S. H.; Corbin, J. D.; Ke, H. Crystal structures of Phosphodiesterases 4 and 5 in Complex with Inhibitor 3-isobutyl-l-Methyl Xanthine suggest a Conformation Determinant of Inhibitor Selectivity. J. Biol. Chem. 2004, 279, 13095-13101.
14. (a) Huai, Q.; Colicelli, J.; Ke, H. The crystal structure of AMP-bound PDE4 Suggests a Mechanism for Phosphodiesterase Catalysis. Biochemistry 2003, 42, 13220-13226.
15. (b) Xu, R. X.; Rocque, W. J.; Lambert, M. H.; Vanderwall, D. E.; Luther, M. A.; Nolte, R. T. Crystal structures of the Catalytic Domain of Phosphodiesterase 4B complexed with AMP, 8-Br-AMP, and Rolipram. J. Mol. Biol. 2004, 337, 355-365.
16. (a) Zhang, K. Y. J.; Card, G. L.; Suzuki, Y.; Artis, D. R.; Fong, D.; Gillette, S.; Hsieh, D.; Neiman, J.; West, B. L.; Zhang, C.; Milburn, M. V.; Kim, S.-H.; Schlessinger, J.; Boliag, G. A. Glutamine Switch Mechanism for Nucleotide Selectivity by Phosphodiesterases. Mol. Cell 2004, 15, 279-286.
17. (b) Card, G. L.; England, B. P.; Suzuki, Y.; Fong, D.; Powell, B.; Lee, B.; Luu, C.; Tabrizizad, M.; Gillette, S.; Ibrahim, P. N.; Artis, D. R.; Bollag, G.; Milburn, M. V.; Kim, S.-H.; Schlessinger, J.; Zhang, K. Y. J. Structural Basis for the Activity of Drugs that Inhibit Phosphodiesterases. Structure 2004, 12, 2233-2247.
18. Card, G. L.; Blasdel, L.; England, B. P.; Zhang, C.; Suzuki, Y.; Gillette, S.; Fong, D.; Ibrahim, P. N.; Artis, D. R.; Bollag, G.; Milburn, M. V.; Kim, S.-H.; Schlessinger, J.; Zhang, K. Y. J. A Family of Phosphodiesterase Inhibitors Discovered by Cocrystallography and Scaffold-based drug design. Nat. Biotechnol. 2005, 23, 201-207.
19. Huai, Q.; Sun, Y.; Wang, H.; Macdonald, D.; Aspiotis, R.; Robinson, H.; Huang, Z.; Ke, H. Enantiomer discrimination Illustrated by the High Resolution Crystal Structures of Type 4 Phosphodiesterase. J. Med. Chem. 2006, 49, 1867-1873.
20. Wang, H.; Peng, M.; Chen, Y.; Geng, J.; Robinson, H.; Houslay, M. D.; Cai, J.; Ke, H. Structures of the Four subfamilies of Phosphodiesterase-4 provide Insight into the Selectivity of their Inhibitors. Biochem. J. 2007, 408, 193-201.
21. Nelson, D. L.; Cox, M. M. Amino acids, peptides and proteins. Lehninger Principles of Biochemistry, 4th ed.; W. H. Freman and Company: 41 Madison Avenue, New York, 2006.
22. 10-Helix along the Thermodynamic Folding Pathway. Biochemistry 1995, 34, 3873-77.
23. 10- and α-Helices. J. Am. Chem. Soc. 2001, 123, 5313-19.
24. 10-Helix in a Three-Residue Peptide Chain: Role of Side Chain-Backbone Interactions as Evidenced by IR-UV Double Resonance Experiments. J. Am. Chem. Soc. 2005, 127, 11900-01.
25. Bindu, P. H.; Sastry, G. M.; Murty, U. S. N.; Sastry, G. N. Structural and Conformational Changes Concomitant with the E1-E2 Transition in H+K+-ATPase: A Comparative Protein Modeling Study. Biochem. Biophys. Res. Commun. 2004, 319, 312-320.
26. MOE version 2006; Chemical Computing Group, 954, First Floor, 16th Main, BTM Layout 2nd Stage, Bangalore, India 560 076.
27. (a) Becke, A. D. Density-functional Thermochemistry. III. The role of exact exchange. J. Chem. Phys. 1993, 98, 5648-5652.
28. (b) Becke, A. D. Density-Functional Exchange-Energy Approximation with Correct Asymptotic Behavior. Phys. Rev. A 1988, 38, 3098-3100.
29. Insight II Version 2000; Molecular Modelling System 2000 Molecular Simulations: 9685 Scrantan Road, San Deigo, CA.
30. Dapprich, S.; Komáromi, I.; Suzie Byun, K.; Morokuma, K.; Frisch, M. J. A new ONIOM implementation in Gaussian98. Part I. The Calculation of Energies, Gradients, Vibrational Frequencies and Electric Field Derivatives. J. Mol. Struct. (Theochem) 1999, 462, 1-21.
31. Vreven, T.; Morokuma, K.; Farkas, Ö.; Schlegel, H. B.; Frisch, M. J. Geometry Optimization with QM/MM, ONIOM, and Other Combined Methods. I. Microiterations and Constraints. J. Comput. Chem. 2003, 24, 760-769.
32. Rappé, A. K.; Casewit, C. J.; Colwell, K. S.; Goddard, W. A., III; Skiff, W. M. UFF, A Full Periodic Table Force Field for Molecular Mechanics and Molecular Dynamics Simulations. J. Am. Chem. Soc. 1992, 114, 10024-35.
33. Gaussian 03, Revision B.03, Frisch, M. J.; Trucks, G. W.; Schlegel, H. B.; Scuseria, G. E.; Robb, M. A.; Cheeseman, J. R.; Montgomery, J. A., Jr.; Vreven, T.; Kudin, K. N.; Burant, J. C.; Millam, J. M.; Iyengar, S. S.; Tomasi, J.; Barone, V.; Mennucci, B.; Cossi, M.; Scalmani, G.; Rega, N.; Petersson, G. A.; Nakatsuji, H.; Hada, M.; Ehara, M.; Toyota, K.; Fukuda, R.; Hasegawa, J.; Ishida, M.; Nakajima, T.; Honda, Y.; Kitao,O.; Nakai, H.; Klene, M.; Li, X.; Knox, J. E.; Hratchian, H. P.; Cross, J. B.; Bakken, V.; Adamo, C.; Jaramillo, J.; Gomperts, R.; Stratmann, R. E.; Yazyev, O.; Austin, A. J.; Cammi, R.; Pomelli, C.; Ochterski, J. W.; Ayala, P. Y.; Morokuma, K.; Voth, G. A.; Salvador, P.; Dannenberg, J. J.; Zakrzewski, V. G.; Dapprich, S.; Daniels, A. D.; Strain, M. C.; Farkas, O.; Malick, D. K.; Rabuck, A. D.; Raghavachari, K.; Foresman, J. B.; Ortiz, J. V.; Cui, Q.; Baboul, A. G.; Clifford, S.; Cioslowski, J.; Stefanov, B. B.; Liu, G.; Liashenko, A.; Piskorz, P.; Komaromi, I.; Martin, R. L.; Fox, D. J.; Keith, T.; Al-Laham, M. A.; Peng, C. Y.; Nanayakkara, A.; Challacombe, M.; Gill, P. M. W. B.; Chen, W.; Wong, M. W.; Gonzalez, C.; Pople, J. A. Gaussian, Inc.: Wallingford, CT, 2003.
34. Case, D. A.; Pearlman, D. A.; Caldwell, J. W.; Cheatham, T. E.; Wang, J.; Ross, W. S.; Simmerling, C.; Darden, T.; Merz, K. M.; Stanton, R. V.; et al. AMBER9, 9th ed.;University of California: San Francisco, CA.
35. Duan, Y.; Wu, C.; Chowdhury, S.; Le, M. C.; Xiong, G.; Zhang, W.; Yang, R.; Cieplak, P.; Luo, R.; Lee, T.; Caldwell, J.; Wang, J.; Kollman, P. A Point-Charge Force Field for Molecular Mechanics Simulations of Proteins Based on Condensed-Phase Quantum Mechanical Calculations. J. Comput. Chem. 2003, 24, 1999-2012.
36. Berendsen, H. J. C.; Postma, J. P. M.; van Gunsteren, W. F.; DiNola, A.; Haak, J. R. Molecular Dynamics with Coupling to An External Bath. J. Chem. Phys. 1984, 81, 3684-90.
37. Darden, T.; York, D.; Pedersen, L. Particle mesh Ewald: An N·log(N) Method For Ewald Sums in Large Systems. J. Chem. Phys. 1993, 98, 10089-92.
38. Wang, H.; Liu, Y.; Huai, Q.; Cai, J.; Zoraghi, R.; Francis, S. H.; Corbin, J. D.; Robinson, H.; Xin, Z.; Lin, G.; Ke, H. Multiple Conformations Of Phosphodiesterase5 Implications For Enzyme Function and Drug Development. J. Biol. Chem. 2006, 281, 21469-21479.
39. (a) Alexov, E. Numerical Calculations of the pH of Maximal Protein Stability. Eur. J. Biochem. 2004, 271, 173-185.
40. (b) Schaefer, M.; Sommer, M.; Karplus, M. pH Dependence of Protein Stability: Absolute Electrostatic Free Energy Differences between Conformations. J. Phys. Chem. 1997, 101, 1663-1683.
41. (c) Antosiewicz, J.; McCammon, J. A.; Gilson, M. K. Prediciton of pH-Dependent Properties of Proteins. J. MoL Biol. 1994, 238, 415-436.
42. (d) Pujato, M.; Navarro, A.; Versace, R.; Mancusso, R.; Ghose, R.; Tasayco, M. L. The pH-dependence of Amide Chemical Shift of Asp/Glu Reflects its pka in Intrinsically Disordered Proteins with Local Interactions. Biochim. Biophys. Acta 2006, 1764, 1227-1233.
43. (e) Thomas, P. G.; Russell, A. J.; Fersht, A. R. Tailoring the pH Dependence of Enzyme Catalysis using Protein Engineering. Nature 1985, 318, 375-376.
44. Gursky, O.; Badger, J.; Li, Y.; Caspar, D. L. Conformational Changes in Cubic Insulin Crystals in the pH Range 7-11. Biophys. J. 1992, 63, 1210-1220.
45. (a) Murthy, J. N.; Nagaraju, M.; Sastry, G. M.; Rao, A. R.; Sastry, G. N. Acitve site acidic residues and structural analysis of modeled human aromatase. J. Comput.-Aided Mol. Des. 2005, 19, 857-870.
46. cam Catalysis: A QM/MM Study. J. Am. Chem. Soc. 2006, 128, 3924-3925.
47. (c) Kumar, D.; Hirao, H.; Shaik, S.; Kozlowski, P. M. Proton-Shuffle Mechanism of O-O Activation for Formation of a High-Valent Oxo-Iron Species of Bleomycin. J. Am. Chem. Soc. 2006, 128, 16148-16158.
48. (a) Lide, D. R. Handbook of Chemistry and Physics, 84th ed.; CRC Press: Boca Raton, FL, 2003.
49. a Values of The Ionizable Groups of Proteins. Protein Sci. 2006, 15, 1214-1218.
50. (c) Dawson, R. M. C.; Elliot, D. C.; Elliot, W. H.; Jones, K. M. Data for biochemical research, 3rd ed.; Clarendon Press: Oxford, 1995.
51. 2+. J. Mol. Biol. 2001, 310, 659-672.
52. (e) Dudev, T.; Lim, C. Factors Governing The Protonation State of Cysteine In Proteins: An Ab initio/CDM study. J. Am. Chem. Soc. 2002, 124, 6759-66.
53. Noar, M. M.; Jenson, J. H. Determinants of Cysteine pKa Values in Creatine Kinase and a-Antitrypsin. Proteins: Struct., Funct., Bioinfor. 2004, 57, 799-803.
54. (a) Marino, T.; Russo, N.; Tocci, E.; Toscano, M. Density Functional Computations of Proton Affinity and Gas-Phase Basicity of Proline. J. Mass. Spectrom. 2001, 36, 301-305.
55. (b) Sapse, A.-M. Molecular orbital calculations for amino acids and peptides; Birkhaüser, Boston, MA, 2000.
56. Joseph, J.; Jemmis, E. D. Red-, Blue-, or No-Shift in Hydrogen Bonds: A Unified Explanation. J. Am. Chem. Soc. 2007, 129, 4620-4632.
57. Krier, M.; de Araújo-J-nior, J. X.; Schmitt, M.; Duranton, J.; Justiano-Basaran, H.; Lugnier, C.; Bourguignon, J.-J.; Rognan, D. Design of Small-Sized Libraries by Combinatorial Assembly of Linkers and Functional Groups to a Given Scaffold: Application to the Structure-Based Optimization of a Phosphodiesterase 4 Inhibitor. J. Med. Chem. 2005, 48, 3816-3822.